Request for Covid-19 Impact Assessment of this Report
The United States Non-opioid Pain Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-opioid Pain Patches market, reaching US$ million by the year 2028. As for the Europe Non-opioid Pain Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-opioid Pain Patches players cover Pfizer, GlaxoSmithKline, Johnson & Johnson, and Novartis AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-opioid Pain Patches Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-opioid Pain Patches by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-opioid Pain Patches by Country/Region, 2017, 2022 & 2028
2.2 Non-opioid Pain Patches Segment by Type
2.2.1 Lidocaine Patch
2.2.2 Diclofenac Patch
2.2.3 Methyl Salicylate Patch
2.2.4 Capsaicin Patch
2.2.5 Ketoprofen Patch
2.2.6 Others
2.3 Non-opioid Pain Patches Sales by Type
2.3.1 Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
2.3.2 Global Non-opioid Pain Patches Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-opioid Pain Patches Sale Price by Type (2017-2022)
2.4 Non-opioid Pain Patches Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Independent Pharmacies & Drug Stores
2.4.3 Online Pharmacies
2.5 Non-opioid Pain Patches Sales by Application
2.5.1 Global Non-opioid Pain Patches Sale Market Share by Application (2017-2022)
2.5.2 Global Non-opioid Pain Patches Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-opioid Pain Patches Sale Price by Application (2017-2022)
3 Global Non-opioid Pain Patches by Company
3.1 Global Non-opioid Pain Patches Breakdown Data by Company
3.1.1 Global Non-opioid Pain Patches Annual Sales by Company (2020-2022)
3.1.2 Global Non-opioid Pain Patches Sales Market Share by Company (2020-2022)
3.2 Global Non-opioid Pain Patches Annual Revenue by Company (2020-2022)
3.2.1 Global Non-opioid Pain Patches Revenue by Company (2020-2022)
3.2.2 Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2022)
3.3 Global Non-opioid Pain Patches Sale Price by Company
3.4 Key Manufacturers Non-opioid Pain Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Pain Patches Product Location Distribution
3.4.2 Players Non-opioid Pain Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-opioid Pain Patches by Geographic Region
4.1 World Historic Non-opioid Pain Patches Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-opioid Pain Patches Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-opioid Pain Patches Annual Revenue by Geographic Region
4.2 World Historic Non-opioid Pain Patches Market Size by Country/Region (2017-2022)
4.2.1 Global Non-opioid Pain Patches Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-opioid Pain Patches Annual Revenue by Country/Region
4.3 Americas Non-opioid Pain Patches Sales Growth
4.4 APAC Non-opioid Pain Patches Sales Growth
4.5 Europe Non-opioid Pain Patches Sales Growth
4.6 Middle East & Africa Non-opioid Pain Patches Sales Growth
5 Americas
5.1 Americas Non-opioid Pain Patches Sales by Country
5.1.1 Americas Non-opioid Pain Patches Sales by Country (2017-2022)
5.1.2 Americas Non-opioid Pain Patches Revenue by Country (2017-2022)
5.2 Americas Non-opioid Pain Patches Sales by Type
5.3 Americas Non-opioid Pain Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Pain Patches Sales by Region
6.1.1 APAC Non-opioid Pain Patches Sales by Region (2017-2022)
6.1.2 APAC Non-opioid Pain Patches Revenue by Region (2017-2022)
6.2 APAC Non-opioid Pain Patches Sales by Type
6.3 APAC Non-opioid Pain Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-opioid Pain Patches by Country
7.1.1 Europe Non-opioid Pain Patches Sales by Country (2017-2022)
7.1.2 Europe Non-opioid Pain Patches Revenue by Country (2017-2022)
7.2 Europe Non-opioid Pain Patches Sales by Type
7.3 Europe Non-opioid Pain Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-opioid Pain Patches by Country
8.1.1 Middle East & Africa Non-opioid Pain Patches Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-opioid Pain Patches Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-opioid Pain Patches Sales by Type
8.3 Middle East & Africa Non-opioid Pain Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Patches
10.3 Manufacturing Process Analysis of Non-opioid Pain Patches
10.4 Industry Chain Structure of Non-opioid Pain Patches
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Pain Patches Distributors
11.3 Non-opioid Pain Patches Customer
12 World Forecast Review for Non-opioid Pain Patches by Geographic Region
12.1 Global Non-opioid Pain Patches Market Size Forecast by Region
12.1.1 Global Non-opioid Pain Patches Forecast by Region (2023-2028)
12.1.2 Global Non-opioid Pain Patches Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-opioid Pain Patches Forecast by Type
12.7 Global Non-opioid Pain Patches Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Non-opioid Pain Patches Product Offered
13.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Non-opioid Pain Patches Product Offered
13.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Non-opioid Pain Patches Product Offered
13.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Novartis AG
13.4.1 Novartis AG Company Information
13.4.2 Novartis AG Non-opioid Pain Patches Product Offered
13.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis AG Main Business Overview
13.4.5 Novartis AG Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Non-opioid Pain Patches Product Offered
13.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 Teva Pharmaceutical Industries
13.6.1 Teva Pharmaceutical Industries Company Information
13.6.2 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Offered
13.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Industries Main Business Overview
13.6.5 Teva Pharmaceutical Industries Latest Developments
13.7 Hisamitsu Pharmaceutical
13.7.1 Hisamitsu Pharmaceutical Company Information
13.7.2 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Offered
13.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hisamitsu Pharmaceutical Main Business Overview
13.7.5 Hisamitsu Pharmaceutical Latest Developments
13.8 TEH SENG Pharmaceutical
13.8.1 TEH SENG Pharmaceutical Company Information
13.8.2 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Offered
13.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 TEH SENG Pharmaceutical Main Business Overview
13.8.5 TEH SENG Pharmaceutical Latest Developments
13.9 Teikoku Seiyaku
13.9.1 Teikoku Seiyaku Company Information
13.9.2 Teikoku Seiyaku Non-opioid Pain Patches Product Offered
13.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teikoku Seiyaku Main Business Overview
13.9.5 Teikoku Seiyaku Latest Developments
13.10 IBSA Institut Biochimque SA
13.10.1 IBSA Institut Biochimque SA Company Information
13.10.2 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Offered
13.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 IBSA Institut Biochimque SA Main Business Overview
13.10.5 IBSA Institut Biochimque SA Latest Developments
13.11 Acorda Therapeutics
13.11.1 Acorda Therapeutics Company Information
13.11.2 Acorda Therapeutics Non-opioid Pain Patches Product Offered
13.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Acorda Therapeutics Main Business Overview
13.11.5 Acorda Therapeutics Latest Developments
13.12 Allergan PLC
13.12.1 Allergan PLC Company Information
13.12.2 Allergan PLC Non-opioid Pain Patches Product Offered
13.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Allergan PLC Main Business Overview
13.12.5 Allergan PLC Latest Developments
13.13 Endo International
13.13.1 Endo International Company Information
13.13.2 Endo International Non-opioid Pain Patches Product Offered
13.13.3 Endo International Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Endo International Main Business Overview
13.13.5 Endo International Latest Developments
14 Research Findings and Conclusion
Table 1. Non-opioid Pain Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-opioid Pain Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Lidocaine Patch
Table 4. Major Players of Diclofenac Patch
Table 5. Major Players of Methyl Salicylate Patch
Table 6. Major Players of Capsaicin Patch
Table 7. Major Players of Ketoprofen Patch
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
Table 11. Global Non-opioid Pain Patches Revenue by Type (2017-2022) & ($ million)
Table 12. Global Non-opioid Pain Patches Revenue Market Share by Type (2017-2022)
Table 13. Global Non-opioid Pain Patches Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Table 16. Global Non-opioid Pain Patches Revenue by Application (2017-2022)
Table 17. Global Non-opioid Pain Patches Revenue Market Share by Application (2017-2022)
Table 18. Global Non-opioid Pain Patches Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Non-opioid Pain Patches Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Non-opioid Pain Patches Sales Market Share by Company (2020-2022)
Table 21. Global Non-opioid Pain Patches Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Non-opioid Pain Patches Revenue Market Share by Company (2020-2022)
Table 23. Global Non-opioid Pain Patches Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Non-opioid Pain Patches Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Patches Products Offered
Table 26. Non-opioid Pain Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-opioid Pain Patches Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Non-opioid Pain Patches Sales Market Share Geographic Region (2017-2022)
Table 31. Global Non-opioid Pain Patches Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Non-opioid Pain Patches Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Non-opioid Pain Patches Sales Market Share by Country/Region (2017-2022)
Table 35. Global Non-opioid Pain Patches Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Non-opioid Pain Patches Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Non-opioid Pain Patches Sales Market Share by Country (2017-2022)
Table 39. Americas Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)
Table 41. Americas Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
Table 43. Americas Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Table 45. APAC Non-opioid Pain Patches Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Non-opioid Pain Patches Sales Market Share by Region (2017-2022)
Table 47. APAC Non-opioid Pain Patches Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Non-opioid Pain Patches Revenue Market Share by Region (2017-2022)
Table 49. APAC Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
Table 51. APAC Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Table 53. Europe Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Non-opioid Pain Patches Sales Market Share by Country (2017-2022)
Table 55. Europe Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)
Table 57. Europe Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
Table 59. Europe Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Non-opioid Pain Patches Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Non-opioid Pain Patches Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Non-opioid Pain Patches Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Non-opioid Pain Patches Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Non-opioid Pain Patches
Table 70. Key Market Challenges & Risks of Non-opioid Pain Patches
Table 71. Key Industry Trends of Non-opioid Pain Patches
Table 72. Non-opioid Pain Patches Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Non-opioid Pain Patches Distributors List
Table 75. Non-opioid Pain Patches Customer List
Table 76. Global Non-opioid Pain Patches Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Non-opioid Pain Patches Sales Market Forecast by Region
Table 78. Global Non-opioid Pain Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Non-opioid Pain Patches Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Non-opioid Pain Patches Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Non-opioid Pain Patches Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Non-opioid Pain Patches Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Non-opioid Pain Patches Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Non-opioid Pain Patches Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Non-opioid Pain Patches Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Non-opioid Pain Patches Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Non-opioid Pain Patches Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Non-opioid Pain Patches Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Non-opioid Pain Patches Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Non-opioid Pain Patches Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Non-opioid Pain Patches Revenue Market Share Forecast by Application (2023-2028)
Table 96. Pfizer Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 97. Pfizer Non-opioid Pain Patches Product Offered
Table 98. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. Pfizer Main Business
Table 100. Pfizer Latest Developments
Table 101. GlaxoSmithKline Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 102. GlaxoSmithKline Non-opioid Pain Patches Product Offered
Table 103. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. GlaxoSmithKline Main Business
Table 105. GlaxoSmithKline Latest Developments
Table 106. Johnson & Johnson Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 107. Johnson & Johnson Non-opioid Pain Patches Product Offered
Table 108. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Johnson & Johnson Main Business
Table 110. Johnson & Johnson Latest Developments
Table 111. Novartis AG Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 112. Novartis AG Non-opioid Pain Patches Product Offered
Table 113. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Novartis AG Main Business
Table 115. Novartis AG Latest Developments
Table 116. Mylan N.V. Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 117. Mylan N.V. Non-opioid Pain Patches Product Offered
Table 118. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Mylan N.V. Main Business
Table 120. Mylan N.V. Latest Developments
Table 121. Teva Pharmaceutical Industries Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 122. Teva Pharmaceutical Industries Non-opioid Pain Patches Product Offered
Table 123. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Teva Pharmaceutical Industries Main Business
Table 125. Teva Pharmaceutical Industries Latest Developments
Table 126. Hisamitsu Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 127. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Offered
Table 128. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Hisamitsu Pharmaceutical Main Business
Table 130. Hisamitsu Pharmaceutical Latest Developments
Table 131. TEH SENG Pharmaceutical Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 132. TEH SENG Pharmaceutical Non-opioid Pain Patches Product Offered
Table 133. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. TEH SENG Pharmaceutical Main Business
Table 135. TEH SENG Pharmaceutical Latest Developments
Table 136. Teikoku Seiyaku Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 137. Teikoku Seiyaku Non-opioid Pain Patches Product Offered
Table 138. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. Teikoku Seiyaku Main Business
Table 140. Teikoku Seiyaku Latest Developments
Table 141. IBSA Institut Biochimque SA Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 142. IBSA Institut Biochimque SA Non-opioid Pain Patches Product Offered
Table 143. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 144. IBSA Institut Biochimque SA Main Business
Table 145. IBSA Institut Biochimque SA Latest Developments
Table 146. Acorda Therapeutics Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 147. Acorda Therapeutics Non-opioid Pain Patches Product Offered
Table 148. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 149. Acorda Therapeutics Main Business
Table 150. Acorda Therapeutics Latest Developments
Table 151. Allergan PLC Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 152. Allergan PLC Non-opioid Pain Patches Product Offered
Table 153. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 154. Allergan PLC Main Business
Table 155. Allergan PLC Latest Developments
Table 156. Endo International Basic Information, Non-opioid Pain Patches Manufacturing Base, Sales Area and Its Competitors
Table 157. Endo International Non-opioid Pain Patches Product Offered
Table 158. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 159. Endo International Main Business
Table 160. Endo International Latest Developments
List of Figures
Figure 1. Picture of Non-opioid Pain Patches
Figure 2. Non-opioid Pain Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Patches Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Non-opioid Pain Patches Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-opioid Pain Patches Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Lidocaine Patch
Figure 10. Product Picture of Diclofenac Patch
Figure 11. Product Picture of Methyl Salicylate Patch
Figure 12. Product Picture of Capsaicin Patch
Figure 13. Product Picture of Ketoprofen Patch
Figure 14. Product Picture of Others
Figure 15. Global Non-opioid Pain Patches Sales Market Share by Type in 2021
Figure 16. Global Non-opioid Pain Patches Revenue Market Share by Type (2017-2022)
Figure 17. Non-opioid Pain Patches Consumed in Hospital Pharmacies
Figure 18. Global Non-opioid Pain Patches Market: Hospital Pharmacies (2017-2022) & (K Pcs)
Figure 19. Non-opioid Pain Patches Consumed in Independent Pharmacies & Drug Stores
Figure 20. Global Non-opioid Pain Patches Market: Independent Pharmacies & Drug Stores (2017-2022) & (K Pcs)
Figure 21. Non-opioid Pain Patches Consumed in Online Pharmacies
Figure 22. Global Non-opioid Pain Patches Market: Online Pharmacies (2017-2022) & (K Pcs)
Figure 23. Global Non-opioid Pain Patches Sales Market Share by Application (2017-2022)
Figure 24. Global Non-opioid Pain Patches Revenue Market Share by Application in 2021
Figure 25. Non-opioid Pain Patches Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Non-opioid Pain Patches Revenue Market Share by Company in 2021
Figure 27. Global Non-opioid Pain Patches Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Non-opioid Pain Patches Revenue Market Share by Geographic Region in 2021
Figure 29. Global Non-opioid Pain Patches Sales Market Share by Region (2017-2022)
Figure 30. Global Non-opioid Pain Patches Revenue Market Share by Country/Region in 2021
Figure 31. Americas Non-opioid Pain Patches Sales 2017-2022 (K Pcs)
Figure 32. Americas Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)
Figure 33. APAC Non-opioid Pain Patches Sales 2017-2022 (K Pcs)
Figure 34. APAC Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)
Figure 35. Europe Non-opioid Pain Patches Sales 2017-2022 (K Pcs)
Figure 36. Europe Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Non-opioid Pain Patches Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Non-opioid Pain Patches Revenue 2017-2022 ($ Millions)
Figure 39. Americas Non-opioid Pain Patches Sales Market Share by Country in 2021
Figure 40. Americas Non-opioid Pain Patches Revenue Market Share by Country in 2021
Figure 41. United States Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Non-opioid Pain Patches Sales Market Share by Region in 2021
Figure 46. APAC Non-opioid Pain Patches Revenue Market Share by Regions in 2021
Figure 47. China Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Non-opioid Pain Patches Sales Market Share by Country in 2021
Figure 54. Europe Non-opioid Pain Patches Revenue Market Share by Country in 2021
Figure 55. Germany Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country in 2021
Figure 62. Egypt Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Non-opioid Pain Patches Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Non-opioid Pain Patches in 2021
Figure 68. Manufacturing Process Analysis of Non-opioid Pain Patches
Figure 69. Industry Chain Structure of Non-opioid Pain Patches
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...